Kimme Hyrich

Kimme Hyrich is a Professor of Epidemiology at the University of Manchester, affiliated with the Centre for Epidemiology Versus Arthritis within the Division of Musculoskeletal and Dermatological Sciences. She is also an Honorary Rheumatology Consultant at Manchester University Hospitals NHS Foundation Trust, UK. Her research focuses on clinical epidemiology of inflammatory arthritis, particularly rheumatoid arthritis and juvenile idiopathic arthritis (JIA), emphasizing real-world effectiveness of biologics, adverse event risks, and long-term outcomes.

• Education:
  • B.Sc. (1992), University of Manitoba, Canada
  • MD (1996), University of Manitoba, Canada
  • PhD (2005), University of Manchester, UK

Her work includes leading the British Society for Rheumatology Biologics Register (BSRBR) and co-leading the MRC Stratified Medicine Consortium for JIA (CLUSTER). She has supervised numerous PhD and Masters students and contributed to global rheumatology through the EULAR COVID-19 Registry and MHRA expert working groups.

Recent research trends involve machine learning in arthritis subgroup identification, methotrexate adverse events, and cardiovascular risks with JAK inhibitors. Her collaborations span international registries and multidisciplinary teams addressing inflammatory diseases.

• Professional Memberships:
  • British Society for Rheumatology (BSR)
  • American College of Rheumatology (ACR)
  • Royal College of Physicians and Surgeons of Canada (RCPSC)
  • Paediatric Rheumatology European Society (PRES)